ArticleStatistics in medicine2026
Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Design, simulate, refine: simulation-guided clinical trials for accelerated drug development.Nature reviews. Drug discovery · 2026Review
- Mapping outcomes in randomised radiology trials: Protocol for a scoping review.Acta radiologica open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The adoption of complex innovative clinical trial designs has steadily increased in recent years. These are trial designs that have one or more unconventional features-often resulting in multiple stages-with the goal of improving on conventional single-stage, fixed-setting designs in terms of efficiency, for example, by reducing the required sample size or the time to establish findings about an intervention. The motivation for these designs may not be difficult to follow, but their set-up and implementation is usually more challenging. Statistical properties of these designs can also be difficult to compute. Clinical trial simulation (CTS), which uses software to generate artificial data for learning, can be conducted to identify the (optimal) setting of a clinical trial, evaluate the design's statistical properties under some hypothetical scenarios for sensitivity analysis, and compare different design set-ups and data analysis strategies, all of which contribute to a better understanding of the value of unconventional features before implementing the design in an actual clinical trial. Existing literature on simulation primarily focuses on the evaluation of statistical analysis methods, with less attention on the detailed specification and planning of CTS. This tutorial presents a new framework, called OCTAVE, for outlining the details of CTS, provides practical recommendations for their implementation, and addresses key computational considerations. The target audience is trial statisticians who are involved in designing and analyzing clinical trials. This tutorial covers a range of complex innovative designs, without the expectation that readers are familiar with the mentioned examples.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.